GINO SANTINI Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
Get free email notifications about insider trading for GINO SANTINI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GINO SANTINI. GINO SANTINI is Director in AMAG PHARMACEUTICALS INC. ($AVM) and President, US Operations in LILLY ELI & CO ($LLY) and Sr.VP, Corp. Strategy & BD in LILLY ELI & CO ($LLY) and Sr.VP, Corp. Strategy & Policy in LILLY ELI & CO ($LLY) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Horizon Pharma plc ($HZNP) and Director in Allena Pharmaceuticals, Inc. ($ALNA).
Over the past year GINO SANTINI has been an insider in 5 companies. The total value of shares held by GINO SANTINI in these companies amounts to $1,711,159.
GINO SANTINI ranks 11,875 out of 350,000 insiders. Go to Insider Ranking to see more.
GINO SANTINI in INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 8,879 shares
Current Value: $1,008,388
Latest Transaction: Jun 01 2020
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY
Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 7,579
Shares Sold: 0
Share Difference: +7,579
Value Difference: $0
Latest Insider Trading Transactions of GINO SANTINI in INTERCEPT PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNA, AVM, COLL, LLY, HZNP, ICPT, VTAE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 72.74 | 2,966 | 215,747 | 2,966 | |
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,595 | 0 | 8,879 | 7.3 K to 8.9 K (+21.90 %) |
| Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 82.25 | 2,174 | 178,812 | 2,174 | |
| Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,570 | 0 | 7,284 | 5.7 K to 7.3 K (+27.48 %) |
| Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
| Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,787 | 0 | 5,714 | 3.9 K to 5.7 K (+45.51 %) |
| Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 122.01 | 2,036 | 248,412 | 2,036 | |
| Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,423 | 0 | 3,927 | 2.5 K to 3.9 K (+56.83 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,204 | 0 | 2,504 | 1.3 K to 2.5 K (+92.62 %) |
| Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 183.62 | 3,500 | 642,670 | 3,500 | |
| Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,300 | 0 | 1,300 | 0 to 1.3 K |
Page: 1